Das «Hörpunkt»-Programm im Überblick: Nicht am Radio zu hören. Diskrete, persönliche Beratung. Beratungstelefon zum Thema «Sex» 16.00-19.00, DRS 2 Fragen, persönliche Probleme zum Thema «Sex»? Sexualpädagogin Marlise Santiago berät im persönlichen Gespräch parallel zum Programm am «Hörpunkt»-Tag von 16.00 bis 19.00 Uhr. Die Telefonnummer wird auf www.drs2.ch und
Conversely, injection forms, though being painful and needing help of medical personnel for application, help to quickly achieve necessary concentration of preparation in blood doxycycline online Antibiotic is usually chosen in an empiric way (at random). But when choosing one is obligatory guided by definite rules.
Microsoft word - l01525 sds.docSECTION 1: CHEMICAL PRODUCT and COMPANY IDENTIFICATION
SECTION 2: HAZARDS IDENTIFICATION Statements of Hazard: Irritant to eyes, skin, mucous membranes and respiratory system. May be harmful by ingestion, inhalation or skin absorption. To the best of our knowledge, the toxicological properties of this chemical have not been thoroughly investigated. Use appropriate procedures and precautions to prevent or minimize exposure. P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P301+P312 IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302+P352 IF ON SKIN: Wash with plenty of soap and water. P304+P340 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 If skin irritation occurs: Get medical advice/ attention. SECTION 3: COMPOSITION/INFORMATION on INGREDIENTS SECTION 4: FIRST AID MEASURES Eye Contact: Flush eyes with large amounts of water for fifteen minutes. Separate eyelids with fingers. If irritation persists, seek medical attention. Wash skin with soap and water. If irritation persists, seek medical attention. Do not induce vomiting. Seek medical attention. Move to a fresh air environment. Contact a physician if breathing becomes difficult. SECTION 5: FIRE FIGHTING MEASURES Flash Point: Carbon dioxide, dry chemical powder, alcohol-resistant foam or water spray. Wear self-contained respirator and fully protective impervious suit. May emit hazardous fumes under fire conditions. SECTION 6: ACCIDENTAL RELEASE MEASURES Personal Protection: Wear a self-contained breathing apparatus, rubber boots and gloves, and disposable coveralls. Dispose of coveralls after use. Keep spills out of sewers and bodies of water. Dike and contain the spill with inert material. Absorb on sand, vermiculite or diatomite. Transfer material to a container for disposal or recovery. Ventilate area and wash spill site after material pickup is complete. SECTION 7: HANDLING and STORAGE Handling: Avoid breathing dust, vapor, mist or gas. Avoid contact with skin and eyes. Avoid prolonged or repeated exposure. Use only in a chemical fume hood. Open and handle container with care. Keep ignition sources away. Store in a tightly closed container in a dry, well-ventilated place. SECTION 8: EXPOSURE CONTROLS/PERSONAL PROTECTION Eyes: Wear appropriate protective eyeglass or chemical safety goggles. Make sure that there is an eyewash facility in your vicinity. Wear impervious gloves and protective clothing. Use a NIOSH approved respirator when exposure limits are exceeded or if irritation or other symptoms are experienced. SECTION 9: PHYSICAL and CHEMICAL PROPERTIES Appearance: SECTION 10: STABILITY and REACTIVITY Stability: Stable under normal temperatures and pressures. Heat, Flame, Sparks, other ignition sources Hazardous Decomposition Products: Carbon oxides, Nitrogen oxides, Hydrogen SECTION 11: TOXICOLOGICAL INFORMATION RTECS Reference: SECTION 13: DISPOSAL CONSIDERATIONS Contact a licensed professional waste disposal service. Dispose in a manner consistent with federal, state and local environmental regulations. SECTION 15: REGULATORY INFORMATION United States: Toxic Substance Control Act (TSCA): Listed Superfund Amendments and Reauthorization Act (SARA 302): Not Available Superfund Amendments and Reauthorization Act (SARA 311/312): Not Available Superfund Amendments and Reauthorization Act (SARA 313): Not Available European Union: European Inventory of Existing Chemical Substances (EINECS): No. 203-232-2 Risk Statements: Not Available Safety Statements: Not Available Canada Canadian Domestic Substances List (DSL): Listed Canadian Domestic Substances List (NDSL): Not Listed SECTION 16: OTHER INFORMATION Date Prepared: The information above is presented in good faith. It is believed to be accurate and represents the best information currently available to us. However we make no warranty with respect to such information and we assume no liability resulting from its use. The user should consider this information as a supplement to other information that may be available and make independent judgment to ensure proper use to protect the health and safety of employees and the environment. Pfaltz and Bauer shall not be held liable for any damage resulting from handling or from contact with the above product.
Guidance for Primary Care on Commencement of Anti-Arrhythmic Therapy Background NSF Chapter 8 has made recommendations on the management of atrial fibrillation. These include the use of sotalol and flecainide, drugs that GPs may be unfamiliar with. The AGW Arrhythmia sub-group has drawn up a protocol for AF management, based on NSF Chapter 8 that includes commencement of sotalol an